Director Cheryl Cohen sold 131,210 shares (131.2K) of IBRX at $9.50 on 2026-07-02 via scheduled 10b5-1 plan; retains 125,386 non-derivative shares plus 111,958 stock options.
Director Cheryl Cohen executed a scheduled sale of 131,210 shares at $9.50, reducing her non-derivative holdings by 51.1% to 125,386 shares. The transaction was part of a pre-arranged 10b5-1 trading plan and therefore represents a scheduled divestment rather than a discretionary decision. While the stock has climbed 28.8% over the prior 30 days and 29.9% over the prior 90 days from the sale date, the underlying company reported a net loss of $632.8M in its most recent full fiscal year, despite posting strong annual revenue growth of 668.3%. Cohen retains meaningful exposure through 111,958 stock options, indicating continued economic alignment with the company even after the partial share reduction.